PRGO

PERRIGO CO PLC

PRGO·G97822103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

PRGO (PERRIGO CO PLC) is held by 154 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($235.9M), Neuberger Berman Group LLC ($111M), VANGUARD PORTFOLIO MANAGEMENT LLC ($94M). Net institutional sentiment: Mixed.

154
Holders
(9 Elite)
$1.4B
Total Value
55% (158)
Consensus
87 buying - 71 selling
13F: Insider & Congress: Updated regularly
PRGO

Smart Money Verdict

View all
Loading verdict
Held by 154 funds
9 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Nov 14, 2025 · Activists Aug 14, 2026 · Congress none

ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.6.3%Aug 14, 2026
ActivistBlackRock, Inc.BlackRock, Inc.15.2%Jul 29, 2026
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.10.2%May 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
22.7M(+32.6%)$235.9M0.0%-23.19%
39
Increased
10.7M(+2.1%)$111M0.1%-27.31%
31
Increased
9M(+11.1%)$94M0.0%+30.73%
33
Increased
8.5M(+18.0%)$88.7M0.0%-42.70%
35
Decreased
7.5M(-2.1%)$77.9M0.2%-1.16%
0
Increased
6.2M(+0.6%)$64.9M0.0%+29.65%
30
Increased
5.9M(+24.5%)$61M0.0%-17.67%
36
Decreased
5.5M(-16.8%)$56.8M0.0%-52.46%
0
Increased
4.4M(+13.5%)$45.7M0.2%+10.83%
40
Increased
3.6M(+58.1%)$37.6M0.0%-42.47%
41
Increased
3.5M(+409.8%)$35.3M0.0%+35.60%
47
Increased
3M(+197.9%)$31.4M0.0%+37.61%
47
Decreased
3M(-30.3%)$31M0.0%-14.49%
0
Decreased
2.4M(-13.0%)$25.1M0.0%-20.88%
0
Increased
1.9M(+1506.4%)$19.5M0.0%+35.45%
46
Increased
1.9M(+40.7%)$19.5M0.0%-39.30%
38
Increased
1.7M(+205.7%)$18.1M0.0%+10.64%
46
Increased
1.6M(+63.1%)$17M0.0%-41.53%
41
Decreased
1.6M(-37.3%)$16.2M0.0%-24.71%
0
Increased
1.5M(+55.2%)$15.9M0.0%+33.76%
40

Showing 1-20 of 167

1 / 9
PRGOPRGOPERRIGO CO PLC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used